Rachele Ciccocioppo, Maria Ester Bernardo, Maria Luisa Russo, Alessandro Vanoli, Carla Franco, Myriam Martinetti, Laura Catenacci, Giovanna Giorgiani, Marco Zecca, Antonio Piralla, Fausto Baldanti, Franco Locatelli, Gino Roberto Corazza
Clinica Medica I, Fondazione IRCCS Policlinico San Matteo, Università degli Studi di Pavia, Piazzale Golgi 19, Pavia, Italy. rachele.ciccocioppo@unipv.it
Journal of pediatric gastroenterology and nutrition 2013 AprWe report on 2 patients affected by both celiac disease (CD) and β-thalassemia major who underwent successful myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) for the latter condition. After HSCT, the introduction of a gluten-containing diet did not cause the reappearance of clinical, serological, and histological markers of CD in up to 5 years of follow-up. After transplantation, in both patients, dendritic cells and regulatory FoxP3T cells showed a recovery of normal values and no proliferative T-cell response upon gliadin stimulation was found. These data suggest that allogeneic HSCT may lead to induction of gluten tolerance in patients with CD.
Rachele Ciccocioppo, Maria Ester Bernardo, Maria Luisa Russo, Alessandro Vanoli, Carla Franco, Myriam Martinetti, Laura Catenacci, Giovanna Giorgiani, Marco Zecca, Antonio Piralla, Fausto Baldanti, Franco Locatelli, Gino Roberto Corazza. Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. Journal of pediatric gastroenterology and nutrition. 2013 Apr;56(4):422-7
PMID: 23531481
View Full Text